You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 4, January 28, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (64)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Journalology/ Peer Review/ Authorship
 •Statistics and Research Methods
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Randomized Controlled Trial Gets a Middle-aged Checkup

Alejandro R. Jadad, MD, DPhil; Drummond Rennie, MD

JAMA. 1998;279:319-320.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Although the first controlled trial in health care is thought to have occurred at least 3 centuries ago, the modern era of randomized controlled trials (RCTs) began in the late 1940s with the pioneering work of Bradford Hill.1 During this 50-year period, RCTs have made important contributions in health care and have been used extensively. Hundreds of thousands of RCTs have been published, and the doubling time in some research areas is less than 10 years.2 The main appeal of the RCT as a research tool in health care derives from its potential for reducing selection bias, particularly during the evaluation of diagnostic or therapeutic interventions. Researchers expect that randomization, if done properly, can keep study groups as similar as possible at the outset, thus enabling the investigators to isolate and quantify the effect of the interventions they are studying and control . . . [Full Text of this Article]

From the Health Information Research Unit, Canadian Cochrane Network and Centre, McMaster Evidence-Based Practice Center, and Department of Clinical Epidemiology and Biostatistics, McMaster University, Toronto, Ontario (Dr Jadad). Dr Rennie is Deputy Editor (West), JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials
John P. A. Ioannidis
JAMA. 1998;279(4):281-286.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Randomized controlled trials in medical education
Parks
JRSM 2009;102:214-214.
FULL TEXT  

Acupuncture for Chronic Pain in Japan: A Review
Itoh and Kitakoji
Evid Based Complement Alternat Med 2007;4:431-438.
ABSTRACT | FULL TEXT  

Relative Citation Impact of Various Study Designs in the Health Sciences
Patsopoulos et al.
JAMA 2005;293:2362-2366.
ABSTRACT | FULL TEXT  

Methodological quality and reporting of ethical requirements in phase III cancer trials
Tuech et al.
J. Med. Ethics 2005;31:251-255.
ABSTRACT | FULL TEXT  

Randomized Controlled Trials
Stolberg et al.
Am. J. Roentgenol. 2004;183:1539-1544.
FULL TEXT  

Effect of Awareness of a Randomized Controlled Trial on Use of Experimental Therapy
Clark et al.
JAMA 2003;290:1351-1355.
ABSTRACT | FULL TEXT  

SYSTEMATIC REVIEWS TO HELP GUIDE CLINICAL PRACTICE IN NEUROMUSCULAR DISEASE
Jewitt and Hughes
J. Neurol. Neurosurg. Psychiatry 2003;74:ii43-44.
FULL TEXT  

Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn
Gottstein and Cooke
Arch. Dis. Child. Fetal Neonatal Ed. 2003;88:F6-10.
ABSTRACT | FULL TEXT  

Methodological quality and reporting of ethical requirements in clinical trials
Ruiz-Canela et al.
J. Med. Ethics 2001;27:172-176.
ABSTRACT | FULL TEXT  

Stretching before exercise: an evidence based approach
Shrier
Br. J. Sports. Med. 2000;34:324-325.
FULL TEXT  

Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity Commentary: Time for a controlled trial?
Deng et al.
BMJ 2000;321:540-545.
ABSTRACT | FULL TEXT  

The Alternative Medicine Handbook: The Complete Reference Guide of Alternative and Complementary Therapies
McPartland
JAMA 1998;280:1635-1636.
FULL TEXT  

Publication Bias and Research on Passive Smoking: Comparison of Published and Unpublished Studies
Misakian and Bero
JAMA 1998;280:250-253.
ABSTRACT | FULL TEXT  

Time Lag Bias in Publishing Clinical Trials
Clarke et al.
JAMA 1998;279:1952-1953.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.